Increasingly, collection of normal and neoplastic human tissue is being incor-
porated in the design of clinical trials and in routine clinical settings under tissue
banking programs. The goal behind these activities is either to facilitate iden-
tification and development of robust predictive or prognostic biomarkers or to
enable basic investigation of tumor or host biology.